These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1540945)

  • 21. Human antibody-dependent cellular cytotoxicity. Isolation and identification of a subpopulation of peripheral blood lymphocytes which kill antibody-coated autologous target cells.
    Brier AM; Chess L; Schlossman SF
    J Clin Invest; 1975 Dec; 56(6):1580-6. PubMed ID: 53242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Defective mononuclear cell antibody-dependent cellular cytotoxicity (ADCC) in patients with leukocyte adhesion deficiency emphasizing on different CD11/CD18 requirement of Fc gamma RI versus Fc gamma RII in ADCC.
    Majima T; Ohashi Y; Nagatomi R; Iizuka A; Konno T
    Cell Immunol; 1993 May; 148(2):385-96. PubMed ID: 8098672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human monocyte-mediated cytotoxicity: the use of Ig-bearing hybridomas as target cells to detect trigger molecules on the monocyte cell surface.
    Graziano RF; Fanger MW
    J Immunol; 1987 Feb; 138(3):945-50. PubMed ID: 2949010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unusually efficient tumor cell lysis by human effectors of antibody-dependent cellular cytotoxicity mediated by monoclonal antibodies.
    Christiaansen JE; Sears DW
    Cancer Res; 1984 Sep; 44(9):3712-8. PubMed ID: 6744288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibody--antigen complex stimulated lysis of non-sensitized sheep red cells by human lymphocytes. I. Requirements for IgG complexes.
    Fuson EW; Shaw MW; Hubbard RA; Lamon EW
    Clin Exp Immunol; 1979 Oct; 38(1):158-65. PubMed ID: 316751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biological activity in the human system of isotype variants of oligosaccharide-Y-specific murine monoclonal antibodies.
    Scholz D; Lubeck M; Loibner H; McDonald-Smith J; Kimoto Y; Koprowski H; Steplewski Z
    Cancer Immunol Immunother; 1991; 33(3):153-7. PubMed ID: 2044080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ADCC against human erythrocyte target cells: role of the anti-target cell antibodies in determining lymphocyte killer activity.
    Nelson DL; Poplack DG; Holiman BJ; Henkart PA
    Clin Exp Immunol; 1979 Mar; 35(3):447-53. PubMed ID: 455783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chimeric and humanized anti-HM1.24 antibodies mediate antibody-dependent cellular cytotoxicity against lung cancer cells.
    Wang W; Nishioka Y; Ozaki S; Jalili A; Verma VK; Hanibuchi M; Abe S; Minakuchi K; Matsumoto T; Sone S
    Lung Cancer; 2009 Jan; 63(1):23-31. PubMed ID: 18524412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colony-stimulating factor enhancement of myeloid effector cell cytotoxicity towards neuroectodermal tumour cells.
    Baldwin GC; Chung GY; Kaslander C; Esmail T; Reisfeld RA; Golde DW
    Br J Haematol; 1993 Apr; 83(4):545-53. PubMed ID: 7686031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-GD3 monoclonal antibody effects on lymphocytes and antibody-dependent cellular cytotoxicity.
    Triozzi PL; Shah JJ; Wang WQ; Aldrich W; Edberg JC; Su K; Carlisle R; Conry R; LoBuglio AF; Forero A
    Cancer Biother Radiopharm; 2006 Dec; 21(6):553-60. PubMed ID: 17257070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymphokine-activated killer cell cytotoxicity against human colon carcinomas enhanced by monoclonal antibody D612.
    Pendurthi TK; Parker R; Schlom J; Primus FJ
    Int J Cancer; 1990 Dec; 46(6):1021-8. PubMed ID: 2123477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cooperation of IgG monoclonal antibodies in macrophage antibody-dependent cellular cytotoxicity (ADCC) to tumor targets.
    Ralph P; Nakoinz I
    J Leukoc Biol; 1984 Jan; 35(1):131-9. PubMed ID: 6584510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Inhibitory effect of human plasma on 17-1A-dependent cellular cytotoxicity].
    Kimoto Y; Taguchi T
    Gan To Kagaku Ryoho; 1987 Feb; 14(2):459-66. PubMed ID: 3813574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heteroantibody-mediated cytotoxicity: antibody to the high affinity Fc receptor for IgG mediates cytotoxicity by human monocytes that is enhanced by interferon-gamma and is not blocked by human IgG.
    Shen L; Guyre PM; Anderson CL; Fanger MW
    J Immunol; 1986 Dec; 137(11):3378-82. PubMed ID: 2946759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced cytotoxicity against colon carcinoma by combinations of noncompeting monoclonal antibodies to the 17-1A antigen.
    Fogler WE; Klinger MR; Abraham KG; Gottlinger HG; Riethmuller G; Daddona PE
    Cancer Res; 1988 Nov; 48(22):6303-8. PubMed ID: 2460221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell-mediated lysis of tumor targets directed by murine monoclonal antibodies of IgM and all IgG isotypes.
    Ralph P; Nakoinz I
    J Immunol; 1983 Aug; 131(2):1028-31. PubMed ID: 6134771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences between the activities of human monoclonal IgG1 and IgG3 anti-D antibodies of the Rh blood group system in their abilities to mediate effector functions of monocytes.
    Wiener E; Jolliffe VM; Scott HC; Kumpel BM; Thompson KM; Melamed MD; Hughes-Jones NC
    Immunology; 1988 Oct; 65(2):159-63. PubMed ID: 3192267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody-dependent cellular cytotoxicity in patients on chronic hemodialysis.
    Koch T; Derer S; Staudinger M; Rossen K; Glorius P; Peipp M; Kellner C; Kunzendorf U; Valerius T; Dechant M
    Am J Nephrol; 2013; 38(5):379-87. PubMed ID: 24157422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The antibody-dependent cell-mediated cytotoxic (ADCC) reaction. III. Lymphocyte, neutrophil and monocyte cytotoxic activity as a function of the alloantibodies and erythrocyte target cells in the human allogeneic ADCC assay.
    Richter M; Richter M; Sklar S
    Clin Invest Med; 1983; 6(1):19-24. PubMed ID: 6831791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased in vivo effector function of human IgG4 isotype antibodies through afucosylation.
    Gong Q; Hazen M; Marshall B; Crowell SR; Ou Q; Wong AW; Phung W; Vernes JM; Meng YG; Tejada M; Andersen D; Kelley RF
    MAbs; 2016; 8(6):1098-106. PubMed ID: 27216702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.